Clinical periodontal diagnosis
GE Salvi, A Roccuzzo, JC Imber, A Stähli… - Periodontology …, 2023 - Wiley Online Library
Periodontal diseases include pathological conditions elicited by the presence of bacterial
biofilms leading to a host response. In the diagnostic process, clinical signs such as …
biofilms leading to a host response. In the diagnostic process, clinical signs such as …
Non–plaque‐induced gingival diseases
P Holmstrup, J Plemons, J Meyle - Journal of clinical …, 2018 - Wiley Online Library
While plaque‐induced gingivitis is one of the most common human inflammatory diseases,
several non–plaque‐induced gingival diseases are less common but often of major …
several non–plaque‐induced gingival diseases are less common but often of major …
Design and discovery of MRTX0902, a potent, selective, brain-penetrant, and orally bioavailable inhibitor of the SOS1: KRAS protein–protein interaction
JM Ketcham, J Haling, S Khare, V Bowcut… - Journal of Medicinal …, 2022 - ACS Publications
SOS1 is one of the major guanine nucleotide exchange factors that regulates the ability of
KRAS to cycle through its “on” and “off” states. Disrupting the SOS1: KRASG12C protein …
KRAS to cycle through its “on” and “off” states. Disrupting the SOS1: KRASG12C protein …
Recent advances in RASopathies
Y Aoki, T Niihori, S Inoue, Y Matsubara - Journal of human genetics, 2016 - nature.com
RASopathies or RAS/mitogen-activated protein kinase (MAPK) syndromes are a group of
phenotypically overlapping syndromes caused by germline mutations that encode …
phenotypically overlapping syndromes caused by germline mutations that encode …
Ras in cancer and developmental diseases
A Fernández-Medarde, E Santos - Genes & cancer, 2011 - journals.sagepub.com
Somatic, gain-of-function mutations in ras genes were the first specific genetic alterations
identified in human cancer about 3 decades ago. Studies during the last quarter century …
identified in human cancer about 3 decades ago. Studies during the last quarter century …
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
WE Tidyman, KA Rauen - Current opinion in genetics & development, 2009 - Elsevier
The Ras/mitogen activated protein kinase (MAPK) pathway is essential in the regulation of
the cell cycle, differentiation, growth and cell senescence, all of which are critical to normal …
the cell cycle, differentiation, growth and cell senescence, all of which are critical to normal …
[HTML][HTML] Targeting son of sevenless 1: the pacemaker of KRAS
Son of Sevenless (SOS) is a guanine nucleotide exchange factor that activates the important
cell signaling switch KRAS. SOS acts as a pacemaker for KRAS, the beating heart of cancer …
cell signaling switch KRAS. SOS acts as a pacemaker for KRAS, the beating heart of cancer …
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
AE Roberts, T Araki, KD Swanson, KT Montgomery… - Nature …, 2007 - nature.com
Noonan syndrome, the most common single-gene cause of congenital heart disease, is
characterized by short stature, characteristic facies, learning problems and leukemia …
characterized by short stature, characteristic facies, learning problems and leukemia …
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome
M Tartaglia, LA Pennacchio, C Zhao, KK Yadav… - Nature …, 2007 - nature.com
Noonan syndrome is a developmental disorder characterized by short stature, facial
dysmorphia, congenital heart defects and skeletal anomalies. Increased RAS-mitogen …
dysmorphia, congenital heart defects and skeletal anomalies. Increased RAS-mitogen …
Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy
TC Hart, MC Gorry, PS Hart, AS Woodard… - Journal of medical …, 2002 - jmg.bmj.com
Introduction: Medullary cystic kidney disease 2 (MCKD2) and familial juvenile
hyperuricaemic nephropathy (FJHN) are both autosomal dominant renal diseases …
hyperuricaemic nephropathy (FJHN) are both autosomal dominant renal diseases …